Regn-cov2 independent data monitoring committee recommends holding enrollment in hospitalized patients with high oxygen requirements and continuing enrollment in patients with low or no oxygen requirements

Tarrytown, n.y., oct. 30, 2020 /prnewswire/ -- the idmc also recommends continuation of enrollment in the regn-cov2 outpatient trial regeneron pharmaceuticals, inc. (nasdaq: regn) received today a recommendation from the independent data monitoring committee (idmc) for the regn-cov2...
REGN Ratings Summary
REGN Quant Ranking